Clinical trials
Phase 1 Neuroectodermal Tumors trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 2 |
| DNAtrix, Inc. | 1 |
| Gradalis, Inc. | 1 |
| Jazz Pharmaceuticals | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
| Merck Sharp & Dohme LLC | 1 |
| National Cancer Institute (NCI) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuroectodermal Tumors | 8 |
| Brain Neoplasms | 4 |
| Central Nervous System Neoplasms | 4 |
| Glioma | 4 |
| Neuroectodermal Tumors, Primitive | 4 |
| Astrocytoma | 3 |
| Ependymoma | 3 |
| Glioblastoma | 3 |
| Gliosarcoma | 3 |
| Medulloblastoma | 3 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.